Go offline with the Player FM app!
$4.4 M Diabetes Patch Brand: Hidden Gem or Hidden Trap?
Manage episode 518165968 series 2842765
In this episode of Acquisitions Anonymous, the hosts dig into a $4.4 M e‑commerce business in the diabetes sensor accessory space and debate whether its 41% net margin, Australian base, and licensing opportunity make it a smart buy—or a risky startup in disguise.
Business Listing – https://websiteproperties.com/websites/13755-sticking-with-success-great-business-opportunity-in-the-growing-diabetes-market/
Welcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.
💰 Sponsored by:
Go High Level – The all-in-one sales and marketing platform built for agencies and entrepreneurs. Automate, manage, and grow your business at https://www.gohighlevel.com
Capital Pad – A platform connecting accredited investors with vetted small business acquisition deals. Discover exclusive opportunities at https://capitalpad.com
The team explores a listing for a home‑based Australian business selling branded adhesive patches for continuous glucose monitors (CGMs) — the listing claims approximately US $3.5 M in trailing 12‑month revenue (converted from AUD) and US $1.46 M in cash‑flow (~41 % net margin). The business model includes Amazon FBA plus a couple of major U.S. pharmacy accounts, with the owner working ~10 hours/week.
Key Highlights:
- Asking price ~US $4.4 M, trailing cash‑flow US $1.46 M (≈41 % net margin)
- Business based in Australia, selling (via Amazon + pharmacies) consumable patches for CGMs — a growing diabetes adjacent market
- Opportunity for U.S. expansion + licensing of characters/brands to build a moat
- Risks: Australian entity, potential Amazon seller‑migration issues, unclear SBA financing, low barrier to entry in consumables
- Strategic path: Use Aussie cash‑flow to buy and build U.S. subsidiary, invest heavily in influencer / TikTok, build brand/licensing to protect margin
Subscribe to weekly our Newsletter and get curated deals in your inbox
Advertise with us by clicking here
- Do you love Acquanon and want to see our smiling faces? Subscribe to our Youtube channel.
- Do you enjoy our content? Rate our show!
- Follow us on Twitter @acquanon Learnings about small business acquisitions and operations.
For inquiries or suggestions, email us at [email protected]
447 episodes
$4.4 M Diabetes Patch Brand: Hidden Gem or Hidden Trap?
Acquisitions Anonymous - #1 for business buying, selling and operating
Manage episode 518165968 series 2842765
In this episode of Acquisitions Anonymous, the hosts dig into a $4.4 M e‑commerce business in the diabetes sensor accessory space and debate whether its 41% net margin, Australian base, and licensing opportunity make it a smart buy—or a risky startup in disguise.
Business Listing – https://websiteproperties.com/websites/13755-sticking-with-success-great-business-opportunity-in-the-growing-diabetes-market/
Welcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.
💰 Sponsored by:
Go High Level – The all-in-one sales and marketing platform built for agencies and entrepreneurs. Automate, manage, and grow your business at https://www.gohighlevel.com
Capital Pad – A platform connecting accredited investors with vetted small business acquisition deals. Discover exclusive opportunities at https://capitalpad.com
The team explores a listing for a home‑based Australian business selling branded adhesive patches for continuous glucose monitors (CGMs) — the listing claims approximately US $3.5 M in trailing 12‑month revenue (converted from AUD) and US $1.46 M in cash‑flow (~41 % net margin). The business model includes Amazon FBA plus a couple of major U.S. pharmacy accounts, with the owner working ~10 hours/week.
Key Highlights:
- Asking price ~US $4.4 M, trailing cash‑flow US $1.46 M (≈41 % net margin)
- Business based in Australia, selling (via Amazon + pharmacies) consumable patches for CGMs — a growing diabetes adjacent market
- Opportunity for U.S. expansion + licensing of characters/brands to build a moat
- Risks: Australian entity, potential Amazon seller‑migration issues, unclear SBA financing, low barrier to entry in consumables
- Strategic path: Use Aussie cash‑flow to buy and build U.S. subsidiary, invest heavily in influencer / TikTok, build brand/licensing to protect margin
Subscribe to weekly our Newsletter and get curated deals in your inbox
Advertise with us by clicking here
- Do you love Acquanon and want to see our smiling faces? Subscribe to our Youtube channel.
- Do you enjoy our content? Rate our show!
- Follow us on Twitter @acquanon Learnings about small business acquisitions and operations.
For inquiries or suggestions, email us at [email protected]
447 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.